BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, February 23, 2026
Home » Authors » Ned Stafford

Articles by Ned Stafford

Novacyt launches two IVD products in EU, cuts 2018 revenue expectations

Dec. 28, 2018
By Ned Stafford

Boston Sci triggers $325M option to acquire full ownership of Millipede

Dec. 28, 2018
By Ned Stafford
HAMBURG, Germany – Boston Scientific Corp. exercised its $325 million option to acquire remaining shares and full ownership of Millipede Inc. upon Millipede's recent successful completion of a first-in-human clinical study of its system treatment of severe mitral regurgitation. Boston Scientific had already invested $90 million in the privately held company in January.
Read More

Digital behavior change firm Changing Health gets £3 million in fresh funds

Dec. 27, 2018
By Ned Stafford

Global team develops fast, portable platform for diagnosing Ebola

Dec. 24, 2018
By Ned Stafford

Allergan suspends EU breast implant sales, share prices plunge on news

Dec. 20, 2018
By Ned Stafford
HAMBURG, Germany – Dublin-based pharmaceutical and medical device firm Allergan plc suspended sales in Europe of its textured breast implants and tissue expanders and is withdrawing any remaining supplies from the market following a compulsory recall request from France's National Agency for the Safety of Medicines and Health Products (ANSM).
Read More

M-health apps for drug use hold potential, but still in infancy, says European study

Dec. 19, 2018
By Ned Stafford

Mobidiag establishes JV in China with Autobio Diagnostics

Dec. 18, 2018
By Ned Stafford

Biomarker test distinguishes epileptic from psychogenic nonepileptic seizures

Dec. 11, 2018
By Ned Stafford

Fresenius group shares plunge after company issues bleak profit warning

Dec. 10, 2018
By Ned Stafford
HAMBURG, Germany – Shares of German health care group Fresenius SE & Co. KGaA plunged Dec. 7 on the Frankfurt Stock Exchange after the company issued a profit warning, saying that it expects stagnant profits in 2019 and believes its group profit targets for 2020 will not be met.
Read More

Scibase, Swiss institute team up to develop new skin diagnostics tool

Dec. 7, 2018
By Ned Stafford
Previous 1 2 3 4 5 6 7 8 9 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • Illustration of brain and antibodies

    VST Bio’s VB-001 is neuroprotector after stroke

    BioWorld Science
    At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing